University of Pennsylvania Researchers Take Step Toward Predicting Parkinson's

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease. The study is reported in JAMA Neurology.

Hey, check out all the engineering jobs. Post your resume today!

Back to news